戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ) were established for supplement-stimulated cholescintigraphy.
2 dder disease were enrolled into quantitative cholescintigraphy.
3 ermined 14 days later using 99mTc-Mebrofenin cholescintigraphy.
4  and liver ultrasonography, and conventional cholescintigraphy.
5 significant differences in specificity among cholescintigraphy (90%; 95% CI: 86%, 93%), US (83%; 95%
6                               Sensitivity of cholescintigraphy (96%; 95% confidence interval [CI]: 94
7 ction fraction induced by cholecystokinin at cholescintigraphy and after disappearance of the recurre
8    Because of enthusiastic acceptance of CCK cholescintigraphy by clinicians, the types of patients r
9                                 Quantitative cholescintigraphy can clearly differentiate one disease
10 llow-up time based on the rationale that CCK cholescintigraphy can quickly confirm or exclude the dia
11 bladder ejection fraction on cholecystokinin-cholescintigraphy (CCK-HIDA) scan.
12 ublications confirming the usefulness of CCK cholescintigraphy had a high pretest likelihood of disea
13 n (GBEF) determined by cholecystokinin (CCK) cholescintigraphy has a high positive predictive value f
14                                              Cholescintigraphy has the highest diagnostic accuracy of
15 asured by (99m)Tc-hepatic iminodiacetic acid cholescintigraphy in 13 healthy subjects.
16           And finally, we must interpret CCK cholescintigraphy in light of the patient's history, pri
17                                 However, CCK cholescintigraphy is now being used by clinicians to sho
18                         Sincalide-stimulated cholescintigraphy is performed to quantify gallbladder c
19                           Morphine-augmented cholescintigraphy optimizes the diagnosis of acute chole
20                           After quantitative cholescintigraphy, the final impression should identify
21    After gallbladder filling on conventional cholescintigraphy, the subjects ingested the supplement
22 d supplement, as an alternative to sincalide cholescintigraphy, to develop a standard methodology, an
23 42 women, 10 men) who underwent quantitative cholescintigraphy twice (total studies, 104), over a mea
24                    Next, we must perform CCK cholescintigraphy using optimal methodology that will re
25 e followed up for months or years before CCK cholescintigraphy was performed, allowing other diseases
26                                              Cholescintigraphy with (99m)Tc-hepatobiliary radiopharma
27 ad received an opioid underwent quantitative cholescintigraphy with octapeptide of CCK (CCK-8).